Autoantibodies against contactin-associated protein-like 2 (CASPR2) are observed in several neurological syndromes, including neuromyotonia (NMT), Morvan syndrome (MoS), and limbic encephalitis.
To characterize the clinical and biological presentations of patients with anti-CASPR2 antibodies in the cerebrospinal fluid (CSF).
Design, Setting, and Participants
JAMA Neurol. Published online July 18, 2016. doi:10.1001/jamaneurol.2016.1585